Italy Swine Vaccines Market Size & Outlook, 2023-2030
Italy swine vaccines market, 2018-2030 (US$M)
Related Markets
Italy swine vaccines market highlights
- The Italy swine vaccines market generated a revenue of USD 41.3 million in 2023 and is expected to reach USD 57.7 million by 2030.
- The Italy market is expected to grow at a CAGR of 4.9% from 2024 to 2030.
- In terms of segment, inactivated (killed) was the largest revenue generating vaccine type in 2023.
- Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids) is the most lucrative vaccine type segment registering the fastest growth during the forecast period.
Swine vaccines market data book summary
| Market revenue in 2023 | USD 41.3 million |
| Market revenue in 2030 | USD 57.7 million |
| Growth rate | 4.9% (CAGR from 2023 to 2030) |
| Largest segment | Inactivated (killed) |
| Fastest growing segment | Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids) |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Modified/ Attenuated Live, Inactivated (Killed), Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids) |
| Key market players worldwide | Merck & Co Inc, CEVA Inc, Zoetis, Boehringer Ingelheim, Elanco Animal Health Inc, Indian Immunologicals, Biogenesis Bago, Phibro Animal Health Corp Class A, Virbac SA |
Other key industry trends
- In terms of revenue, Italy accounted for 2.5% of the global swine vaccines market in 2023.
- Country-wise, China is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany swine vaccines market is projected to lead the regional market in terms of revenue in 2030.
- Norway is the fastest growing regional market in Europe and is projected to reach USD 7.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Swine Vaccines Market Scope
Swine Vaccines Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Italy swine vaccines market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to swine vaccines market will help companies and investors design strategic landscapes.
Inactivated (killed) was the largest segment with a revenue share of 37.77% in 2023. Horizon Databook has segmented the Italy swine vaccines market based on modified/ attenuated live, inactivated (killed), other vaccines (e.g. recombinant, dna, subunit, or toxoids) covering the revenue growth of each sub-segment from 2018 to 2030.
African swine fever and other zoonotic diseases are expected to drive market growth. Due to an outbreak of African swine fever, 1,000 pigs were slaughtered in June 2022 after two cases of swine fever were discovered on a farm in Rome's Lazio region.
As a result, the Italian Council of Ministers approved a decree law including urgent measures to prevent the spread of African swine fever in the country. Furthermore, increasing initiatives undertaken by the Italian government are likely to promote market growth.
Furthermore, animals are increasingly being used in a variety of research studies in Italy. According to the latest figures, 611,707 animal treatments were performed in Italy in 2017. An increased prevalence of a variety of animal diseases in Italy is expected to drive the demand for animal vaccines.
Reasons to subscribe to Italy swine vaccines market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Italy swine vaccines market databook
-
Our clientele includes a mix of swine vaccines market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy swine vaccines market , including forecasts for subscribers. This country databook contains high-level insights into Italy swine vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Italy swine vaccines market size, by vaccine type, 2018-2030 (US$M)
Italy Swine Vaccines Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
